Castle Biosciences's total assets for Q2 2025 were $544.73M, an increase of 8.57% from the previous quarter. CSTL total liabilities were $89.35M for the fiscal quarter, a 45.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.